Although the frequency of point mutations in PIK3CA was low, we found copy number amplification in 37 samples (32.2%), suggesting that the hyper activation of the PI3K pathway occurs in one-third of HNSCC patients. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.